Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.42 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.42 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3392546 | 0.97 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL4393272 | 0.89 | — | — | |
| SCHEMBL3392872 | 0.88 | ALDH1A1 (0.56) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL12924716 | 0.87 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL15430832 | 0.87 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL12924709 | 0.87 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL12924712 | 0.87 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL12924703 | 0.87 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL12924728 | 0.87 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL4393268 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100003679-A1 | ASSESSMENT OF CELLULAR COMPOSITION AND FRACTIONAL VIABILITY AND USES THEREOF | UNIVERSITY OF MIAMI (US) | 2010-01-07 | — | — | US | claimed |
| EP-2029726-A2 | ASSESSMENT OF CELLULAR COMPOSITION AND FRACTIONAL VIABILITY AND USES THEREOF | University of Miami (US) | 2009-03-04 | — | — | EP | claimed |
| WO-2007146811-A2 | ASSESSMENT OF CELLULAR COMPOSITION AND FRACTIONAL VIABILITY AND USES THEREOF | UNIVERSITY OF MIAMI (US) | 2007-12-21 | — | — | WO | claimed |
| JP-4217940-A | — | — | None | — | — | JP | disclosed |
| US-20250304529-A1 | BIOBASED CYANOACRYLATE COMPOUND | BOSTIK SA (FR) | 2025-10-02 | — | — | US | disclosed |
| EP-4532465-A1 | BIOBASED CYANOACRYLATE COMPOUND | Bostik SA (FR) | 2025-04-09 | — | — | EP | disclosed |
| CN-115068468-B | Carboxylic aromatic amides as bradykinin B1 receptor antagonists | 拜耳制药股份公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119451941-A | Bio-based cyanoacrylate compounds | 博斯蒂克股份公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-119097698-A | Inhibitors of mevalonate pathway as efficient vaccine adjuvants | 清华大学 | 2024-12-10 | — | — | CN | disclosed |
| CN-114848656-B | Inhibitors of mevalonate pathway as efficient vaccine adjuvants | 清华大学 | 2024-09-27 | — | — | CN | disclosed |
| CN-115137726-B | Carboxylic aromatic amides as bradykinin B1 receptor antagonists | 拜耳制药股份公司 | 2024-08-13 | — | — | CN | disclosed |
| EP-0165164-A1 | Anti-viral compounds, their preparation and anti-viral compositions | MERCK & CO. INC. (US) | 1985-12-18 | — | — | EP | disclosed |
| EP-0074306-A2 | Anti-viral guanine derivatives | MERCK & CO. INC. (US) | 1983-03-16 | — | — | EP | disclosed |
| EP-0074306-A2 | Anti-viral guanine derivatives | MERCK & CO. INC. (US) | 1983-03-16 | — | — | EP | disclosed |
| US-4123552-A | FUNGICIDES | CHEVRON RESEARCH COMPANY (US) | 1978-10-31 | — | — | US | disclosed |
| US-4100200-A | Use of novel ethers as oxydimethylating agents | EASTMAN KODAK COMPANY (US) | 1978-07-11 | — | — | US | disclosed |
| US-4025542-A | Novel ethers, their preparation and use as oxydimethylating agents | EASTMAN KODAK COMPANY (US) | 1977-05-24 | — | — | US | disclosed |
| US-4021475-A | FROM ESTERS OF POLYOXYMETHYLENE GLYCOL AND PHENOLS | EASTMAN KODAK COMPANY (US) | 1977-05-03 | — | — | US | disclosed |
| US-4012526-A | Oxymethylene di-carboxylic acid esters as anti-fungal agents and animal growth promoters | CHEVRON RESEARCH COMPANY (US) | 1977-03-15 | — | — | US | disclosed |
| US-3931412-A | Fungus and bacteria control with di-carboxylic acid esters | CHEVRON RESEARCH COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304529-A1 | BIOBASED CYANOACRYLATE COMPOUND | BAP1, CBR1, CBR3 | ALDH1A1 95/4885LMNA 992/4885HSD17B10 855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.